We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BRTX market cap is 11.58M. The company's latest EPS is USD -2.1293 and P/E is -0.80.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 31k | 65k | 31k | 19k | 35k |
| Operating Income | -5.78M | -3.12M | -3.1M | -3.22M | -4.11M |
| Net Income | -5.68M | -2.98M | -2.93M | -2.83M | -2.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 130k | 77k | 46k | 120k | 146k |
| Operating Income | -8.43M | -2.75M | -26.31M | -18.97M | -15.22M |
| Net Income | -14.65M | -11.27M | -44.3M | -18.49M | -14.42M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.08M | 13.3M | 13.8M | 12.61M | 17.95M |
| Total Liabilities | 594k | 896k | 975k | 1.06M | 3.45M |
| Total Equity | 13.49M | 12.4M | 12.83M | 11.55M | 14.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.47M | 4.35M | 22.45M | 16.43M | 12.61M |
| Total Liabilities | 14.24M | 5.68M | 857k | 602k | 1.06M |
| Total Equity | -12.78M | -1.33M | 21.6M | 15.83M | 11.55M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.35M | -3.48M | -4.66M | -6.43M | -2.32M |
| Investing | 2.51M | 3.17M | 3.15M | 3.25M | -4.93M |
| Financing | N/A | 412k | 2.27M | 2.35M | 7.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.92M | -1.96M | -3.33M | -5.87M | -6.43M |
| Investing | -36k | N/A | -31k | -13.48M | 3.25M |
| Financing | 6.84M | 5.03M | 21.32M | N/A | 2.35M |
| Market Cap | 11.58M |
| Price to Earnings Ratio | -0.80 |
| Price to Sales Ratio | 79.17 |
| Price to Cash Ratio | 13.09 |
| Price to Book Ratio | 1 |
| Dividend Yield | - |
| Shares Outstanding | 6.77M |
| Average Volume (1 week) | 32.85k |
| Average Volume (1 Month) | 73.48k |
| 52 Week Change | -37.13% |
| 52 Week High | 3.6699 |
| 52 Week Low | 1.03 |
| Spread (Intraday) | 0.03 (1.74%) |
| Company Name | BioRestorative Therapies Inc |
| Address |
874 walker rd ste c dover, delaware 19904 |
| Website | https://www.biorestorative.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
